Toronto, Ontario – December 30, 2019 – Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the press release dated December 23, 2019, it has closed its acquisition (the “Acquisition”) of all of the...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has entered into a binding Letter of Intent (the “LOI”) to acquire all of the common shares of Canmart Limited (“Canmart”) in the...

Halo Labs Inc. (“Halo” or the “Company”) (NEO:HALO, OTCQX:AGEEF, Germany:A9KN) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) to acquire all of the common shares of Precisa Medical Instruments Corp. (“Precisa”) for C$3,750,000 in...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) would like to thank King Letsie III and Queen Masenate Mohato Seeiso of Lesotho for touring the Bophelo Bioscience’s (“Bophelo”) Cannabis cultivation site in Mafeteng, Lesotho today....

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has completed its transaction (the “Transaction”) with Ukiah Ventures Inc. (“Ukiah”) that was previously announced on August 28, 2019. Pursuant to...

Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has signed a strategic partnership agreement with OG DNA Genetics Inc. (“DNA Genetics”), one of the most awarded names in cannabis,...